Relapse related to drug resistance in leprosy

Detalhes bibliográficos
Autor(a) principal: Diório, Suzana Madeira
Data de Publicação: 2009
Outros Autores: Rosa, Patrícia Sammarco, Belone, Andréa de Faria Fernandes, Sartori, Beatriz Gomes Carreira, Trino, Lazara Moreira, Baptista, Ida Maria Foschiani Dias, Marcos, Elaine Valim Camarinha, Barreto, Jaison Antonio, Ura, Somei
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Hansenologia Internationalis (Online)
Texto Completo: https://periodicos.saude.sp.gov.br/hansenologia/article/view/35162
Resumo: The multidrugtherapy proposed by the World Health Organization has been effectively implemented in Brazil in 1991. It helped reduce the prevalence and achieve the cure of leprosy. However, its proven efficacy has not prevented the occurrence of relapses in some leprosy patients. Irregular treatment, bacillary persistence or resistance of Mycobacterium leprae to drugs are factors that may be associated with relapse. The objective of this study was assess the occurrence of relapse and associate it with the presence of Mycobacterium leprae resistant strains. In order to do that, 28 individuals who were clinically diagnosed as relapse after treatment with sulphone monotherapy, the National Division of Sanitary Dermatology scheme or multidrugtherapy. Biopsies from lesions of multibacillary patients attended by spontaneous demand were collected to verifyresistance to drugs through the mouse foot pad inoculation technique. Among the samples evaluated 42.8% had bacilli susceptible to dapsone and rifampicin and 10.7% showed resistance to dapsone. No rifampicin resistant bacilli were isolated. The emergence of resistant strains, especially to rifampicin, is a threat to leprosy control programs, therefore, monitoring the spread of these strains is important because resistance pose a serious obstacle to the elimination of disease, particularly in countries where the disease is endemic.
id ILSL-1_6145aa1db035b1daa7e6d78689b8fb7e
oai_identifier_str oai:ojs.periodicos.saude.sp.gov.br:article/35162
network_acronym_str ILSL-1
network_name_str Hansenologia Internationalis (Online)
repository_id_str
spelling Relapse related to drug resistance in leprosyRecidivas associadas à resistência a drogas na hanseníaseMycobacterium lepraehanseníaserecidivaresistência a drogasMycobacterium lepraeleprosyrelapsedrugs resistanceThe multidrugtherapy proposed by the World Health Organization has been effectively implemented in Brazil in 1991. It helped reduce the prevalence and achieve the cure of leprosy. However, its proven efficacy has not prevented the occurrence of relapses in some leprosy patients. Irregular treatment, bacillary persistence or resistance of Mycobacterium leprae to drugs are factors that may be associated with relapse. The objective of this study was assess the occurrence of relapse and associate it with the presence of Mycobacterium leprae resistant strains. In order to do that, 28 individuals who were clinically diagnosed as relapse after treatment with sulphone monotherapy, the National Division of Sanitary Dermatology scheme or multidrugtherapy. Biopsies from lesions of multibacillary patients attended by spontaneous demand were collected to verifyresistance to drugs through the mouse foot pad inoculation technique. Among the samples evaluated 42.8% had bacilli susceptible to dapsone and rifampicin and 10.7% showed resistance to dapsone. No rifampicin resistant bacilli were isolated. The emergence of resistant strains, especially to rifampicin, is a threat to leprosy control programs, therefore, monitoring the spread of these strains is important because resistance pose a serious obstacle to the elimination of disease, particularly in countries where the disease is endemic.A poliquimioterapia/Organização Mundial da Saúde foi implantada efetivamente no Brasil em 1991, contribuindo drasticamente para redução da taxa de prevalência e cura da hanseníase. No entanto, a sua comprovada eficácia não tem impedido a ocorrência de recidiva da doença. Falha no tratamento, persistência bacilar ou resistência a drogas são fatores que podem ou não estarem associados a ela. O objetivo deste estudo foi verificar a ocorrência de recidiva e associá-la com a presença de cepas resistentes do Mycobacterium leprae entre 28 indivíduos que apresentaram suspeita clínica de recidiva após tratamento por monoterapia sulfônica, esquema da Divisão Nacional de Dermatologia Sanitária ou poliquimioterapia. Biópsias das lesões de pacientes multibacilares, com diagnóstico clínico de recidiva, atendidos por demanda espontânea, foram coletadas para avaliar resistência a drogas por meio da técnica de inoculação em pata de camundongo. Dentre as amostras avaliadas 42,8% apresentaram bacilos sensíveis à dapsona e rifampicina e 10,7% apresentaram resistência à dapsona; não foram isolados bacilos resistentes à rifampicina. A emergência de bacilos resistentes, especialmente à rifampicina, é um alerta para os programas de controle da hanseníase. Monitorar a disseminação destas cepas é importante, pois elas apresentam um sério obstáculo para a eliminação da doença, principalmente em países onde a hanseníase ainda é endêmica.Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo2009-06-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAvaliado pelos paresapplication/pdfapplication/pdfhttps://periodicos.saude.sp.gov.br/hansenologia/article/view/3516210.47878/hi.2009.v34.35162Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 34 No. 1 (2009); 37-42Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 34 n. 1 (2009); 37-421982-5161reponame:Hansenologia Internationalis (Online)instname:Instituto Lauro de Souza Lima (ILSL)instacron:ILSLporenghttps://periodicos.saude.sp.gov.br/hansenologia/article/view/35162/33632https://periodicos.saude.sp.gov.br/hansenologia/article/view/35162/33633Diório, Suzana MadeiraRosa, Patrícia SammarcoBelone, Andréa de Faria FernandesSartori, Beatriz Gomes CarreiraTrino, Lazara MoreiraBaptista, Ida Maria Foschiani DiasMarcos, Elaine Valim CamarinhaBarreto, Jaison AntonioUra, Someiinfo:eu-repo/semantics/openAccess2021-06-05T23:31:41Zoai:ojs.periodicos.saude.sp.gov.br:article/35162Revistahttps://periodicos.saude.sp.gov.br/hansenologiaPRIhttps://periodicos.saude.sp.gov.br/hansenologia/oaihansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br1982-51610100-3283opendoar:2021-06-05T23:31:41Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL)false
dc.title.none.fl_str_mv Relapse related to drug resistance in leprosy
Recidivas associadas à resistência a drogas na hanseníase
title Relapse related to drug resistance in leprosy
spellingShingle Relapse related to drug resistance in leprosy
Diório, Suzana Madeira
Mycobacterium leprae
hanseníase
recidiva
resistência a drogas
Mycobacterium leprae
leprosy
relapse
drugs resistance
title_short Relapse related to drug resistance in leprosy
title_full Relapse related to drug resistance in leprosy
title_fullStr Relapse related to drug resistance in leprosy
title_full_unstemmed Relapse related to drug resistance in leprosy
title_sort Relapse related to drug resistance in leprosy
author Diório, Suzana Madeira
author_facet Diório, Suzana Madeira
Rosa, Patrícia Sammarco
Belone, Andréa de Faria Fernandes
Sartori, Beatriz Gomes Carreira
Trino, Lazara Moreira
Baptista, Ida Maria Foschiani Dias
Marcos, Elaine Valim Camarinha
Barreto, Jaison Antonio
Ura, Somei
author_role author
author2 Rosa, Patrícia Sammarco
Belone, Andréa de Faria Fernandes
Sartori, Beatriz Gomes Carreira
Trino, Lazara Moreira
Baptista, Ida Maria Foschiani Dias
Marcos, Elaine Valim Camarinha
Barreto, Jaison Antonio
Ura, Somei
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Diório, Suzana Madeira
Rosa, Patrícia Sammarco
Belone, Andréa de Faria Fernandes
Sartori, Beatriz Gomes Carreira
Trino, Lazara Moreira
Baptista, Ida Maria Foschiani Dias
Marcos, Elaine Valim Camarinha
Barreto, Jaison Antonio
Ura, Somei
dc.subject.por.fl_str_mv Mycobacterium leprae
hanseníase
recidiva
resistência a drogas
Mycobacterium leprae
leprosy
relapse
drugs resistance
topic Mycobacterium leprae
hanseníase
recidiva
resistência a drogas
Mycobacterium leprae
leprosy
relapse
drugs resistance
description The multidrugtherapy proposed by the World Health Organization has been effectively implemented in Brazil in 1991. It helped reduce the prevalence and achieve the cure of leprosy. However, its proven efficacy has not prevented the occurrence of relapses in some leprosy patients. Irregular treatment, bacillary persistence or resistance of Mycobacterium leprae to drugs are factors that may be associated with relapse. The objective of this study was assess the occurrence of relapse and associate it with the presence of Mycobacterium leprae resistant strains. In order to do that, 28 individuals who were clinically diagnosed as relapse after treatment with sulphone monotherapy, the National Division of Sanitary Dermatology scheme or multidrugtherapy. Biopsies from lesions of multibacillary patients attended by spontaneous demand were collected to verifyresistance to drugs through the mouse foot pad inoculation technique. Among the samples evaluated 42.8% had bacilli susceptible to dapsone and rifampicin and 10.7% showed resistance to dapsone. No rifampicin resistant bacilli were isolated. The emergence of resistant strains, especially to rifampicin, is a threat to leprosy control programs, therefore, monitoring the spread of these strains is important because resistance pose a serious obstacle to the elimination of disease, particularly in countries where the disease is endemic.
publishDate 2009
dc.date.none.fl_str_mv 2009-06-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.saude.sp.gov.br/hansenologia/article/view/35162
10.47878/hi.2009.v34.35162
url https://periodicos.saude.sp.gov.br/hansenologia/article/view/35162
identifier_str_mv 10.47878/hi.2009.v34.35162
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://periodicos.saude.sp.gov.br/hansenologia/article/view/35162/33632
https://periodicos.saude.sp.gov.br/hansenologia/article/view/35162/33633
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo
publisher.none.fl_str_mv Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo
dc.source.none.fl_str_mv Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 34 No. 1 (2009); 37-42
Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 34 n. 1 (2009); 37-42
1982-5161
reponame:Hansenologia Internationalis (Online)
instname:Instituto Lauro de Souza Lima (ILSL)
instacron:ILSL
instname_str Instituto Lauro de Souza Lima (ILSL)
instacron_str ILSL
institution ILSL
reponame_str Hansenologia Internationalis (Online)
collection Hansenologia Internationalis (Online)
repository.name.fl_str_mv Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL)
repository.mail.fl_str_mv hansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br
_version_ 1796797578839326720